99%+ Purity
COA Included
Sealed Vials
CJC-1295 (No DAC)
GHRH analog for pulsatile GH release
GH pulses
Key Benefits
- Preserves natural pulsatile GH release patterns
- May support healthy IGF-1 production
- Works with body's circadian rhythms
- Supports physiological hormone balance
- May enhance protein synthesis processes
- Maintains natural growth hormone physiology
- Short half-life prevents receptor desensitization
About CJC-1295 (No DAC)
CJC-1295 (No DAC) represents a breakthrough in growth hormone research, designed to work with your body's natural rhythms rather than against them. This advanced peptide functions as a synthetic analog of growth hormone-releasing hormone, specifically engineered to stimulate your pituitary gland's natural GH production while preserving the crucial pulsatile release patterns that your body depends on for optimal function. Research suggests that CJC-1295 (No DAC) may support healthy growth hormone levels by binding to specific receptors in the anterior pituitary, triggering a carefully orchestrated cascade of cellular events that culminate in natural GH secretion. What sets the No DAC version apart is its ability to maintain physiological pulsatility - the natural ebb and flow of hormone release that mirrors your body's circadian rhythms. This targeted approach may support the downstream production of IGF-1, a key mediator of growth hormone's beneficial effects on protein synthesis, cellular repair processes, and metabolic function, while minimizing the risk of receptor desensitization associated with continuous hormone exposure.
Research Background
CJC-1295 represents an advancement in growth hormone-releasing hormone (GHRH) analog development, specifically designed to address limitations of natural GHRH's short half-life. The peptide works by binding to specific GHRH receptors in the pituitary gland, triggering a cascade of cellular events that ultimately leads to growth hormone secretion. Research has identified two distinct versions: the DAC (Drug Affinity Complex) version and the no-DAC version, each with unique pharmacological profiles and potential applications.
The primary research focus centers on understanding how these two versions differ in their ability to maintain physiological GH pulsatility. The no-DAC version preserves the body's natural pulsatile GH release pattern, which is crucial for optimal metabolic function and minimizing side effects. This pulsatile pattern is important because continuous GH exposure can lead to receptor desensitization and metabolic complications. Current research directions include: 1) Optimizing dosing protocols to maximize benefits while maintaining safety, 2) Investigating therapeutic applications in age-related GH decline and muscle wasting conditions, and 3) Understanding long-term effects on body composition, bone health, and metabolic parameters.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 100 mcg | |
Intermediate | 200 mcg | |
Advanced | 300-500 mcg | |
Maximum | 1 mg |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
4
33.6 mg needed ÷ 10 per vial
Total Investment
$280
$70.00 per vial
Per Dose
0.04 mL
4 units on U-100 syringe
Doses per Vial
50
10 ÷ 0.20 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
Related Products
CJC-1295 (DAC)
Long-acting GHRH analog for sustained GH elevation
CJC-1295 / Ipamorelin
CJC-1295 and Ipamorelin are designed for clients who want measurable performance, recovery, and longevity benefits—without crossing the line into hormone replacement or system shutdown. This is not synthetic HGH and it’s not a short-term hack. It’s a disciplined, physiology-first approach that restores the body’s own growth hormone signaling, which naturally declines with age, stress, poor sleep, and overtraining. CJC-1295 works upstream at the pituitary level, enhancing the quality, duration, and consistency of natural GH release, while Ipamorelin acts as a precision trigger—stimulating GH without the cortisol spikes, prolactin elevation, or hunger issues associated with older compounds. Together, they create smoother, more youthful GH pulses that the body actually knows how to use. From a client experience standpoint, this shows up where it matters: deeper, more restorative sleep; faster recovery between workouts or long workdays; improved fat metabolism; better skin and tissue quality; and a noticeable improvement in overall resilience. There’s no suppression of natural production, no dependency risk, and no hormonal rollercoaster—making it appropriate for long-term use and scalable protocols. For many clients, this stack becomes the foundation layer they build everything else on, because it improves how the body repairs, adapts, and recovers across the board. In short, this is growth hormone optimization for adults who play the long game—subtle, sustainable, and designed to deliver compounding returns over time.
Fragment 176-191
HGH fat-burning fragment
CJC-1295 (No DAC)
$70.00